Innovator Capital was founded originally to assist Life Science companies and entrepreneurs. Mungo Park, its Executive Chairman has devoted over 30 years to this industry beginning in 1978 with the IPO of Genentech. He was involved in similar transactions with companies such as Amgen, Biogen, Genzyme and at least 50 more subsequently. The firm takes on a few new projects every year; invariably these are disease indication specific and where the companies can benefit from Innovator’s wealth of strategic, intellectual property and finance knowledge.